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Abstract: We assessed 12 urine metals in tobacco smoke-exposed and not exposed National 
Health  and  Nutrition  Examination  Survey  participants.  Our  analysis  included  age, 
race/ethnicity, and poverty status. Gender and racial/ethnic differences in cadmium and lead 
and creatinine-adjusted and unadjusted data for group comparisons are presented. Smokers’ 
had  higher  cadmium,  lead,  antimony,  and  barium  levels  than  nonsmokers.  Highest  lead 
levels  were  in  the  youngest  subjects.  Lead  levels  among  adults  with  high  second-hand 
smoke  exposure  equaled  smokers.  Older  smokers  had  cadmium  levels  signaling  the 
potential for cadmium-related toxicity. Given the potential toxicity of metals, our findings 
complement existing research on exposure to chemicals in tobacco smoke. 
Keywords:  secondhand  smoke  (SHS);  metals;  youth;  lead;  cadmium;  race/ethnicity; 
tobacco smoke; smoker; toxicity 
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1. Introduction 
 
Cigarette smoke inhaled by a smoker contains more than 4,000 chemicals [1], and second hand 
smoke (SHS) is qualitatively similar [1]. Metals in tobacco smoke are of public health concern because 
of their potential toxicity and carcinogenicity [2]. Some are linked to adverse health outcomes such as 
cardiovascular and renal disease and impaired lung function among smokers [3-7]. Because the dose of 
toxic chemicals received by a smoker is an important factor in the harm caused by tobacco, analysis of 
the National Health and Nutrition Examination Survey (NHANES) exposure data suggests promising 
candidate chemicals for determining whether reductions of certain toxic constituents in cigarettes and 
cigarette smoke translate into reductions in active and passive smokers’ exposure to these substances. 
Prevention of tobacco use and SHS exposure remains a critically important public health priority. 
The Surgeon General recently concluded that there is no safe level of SHS exposure [1,8]. Although 
significant progress has been made to reduce SHS exposure, nearly half (46.4%) of U.S. nonsmokers 
remain exposed [9]. 
The NHANES  is a  vital source of population-level exposure data for environmental pollutants, 
including  tobacco  smoke.  Population-level  data  is  important  to  assess  the  magnitude  of  various 
exposures and the impact of laws and policies aimed at tobacco use and SHS exposure [2,10]. All 12 
of the metals in this study (antimony (Sb), barium (Ba), beryllium (Be), cadmium (Cd), cesium (Cs), 
cobalt  (Co),  lead  (Pb),  mercury  (Hg),  molybdenum  (Mo),  platinum  (Pt),  thallium  (Tl),  and  
tungsten (W)) have been reported in tobacco smoke [11,12]. Some metals, such as cadmium and lead, 
are widely recognized for their toxicity and tendency to accumulate in the body [13,14].
 While noting 
that no one threshold for all adverse effects from lead exposure has been demonstrated, and that the 
available evidence has important limitations including the small number of studies of peak blood lead 
levels below 10 µg/dL in children never known to have a blood lead level exceeding 10 µg/dL, the 
CDC has concluded that the data demonstrates that no level of lead in a child’s blood can be specified 
as safe [15,16]. Other metals, such as cobalt, have beneficial or harmful effects, depending on the level 
of exposure [17]. 
This study examined  levels of urinary  metals among cigarette smoke exposed  and not exposed 
NHANES participants. Unlike previous studies that focused on a select few metals [5,6], we included 
12 metals to provide population-level, baseline exposure data for a large number of potentially toxic 
metals. We analyzed urine data because, while influenced by pharmacokinetics, urine measurements 
are  a  useful  noninvasive  approach  in  biomonitoring  research  of  exposures  to  metals  and  other 
environmental pollutants [18-21]. The findings from this study contribute to the limited information 
available regarding exposure to potentially toxic metals in tobacco smoke. By analyzing data for both 
active and passive smokers, we provide information to strengthen public health messages regarding 
quitting smoking, to increase awareness of the dangers of SHS exposure, and the need for strategies to 
further reduce SHS exposure.  
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2. Results and Discussion 
 
The  unweighted  sample  by  demographic  characteristic  is  presented  for  all  metals  (Table  1). 
Approximately equal numbers of males and females are present among participants and most were 
above the poverty threshold. 
 
Table 1. Sample Size by Demographic Characteristics for 12 Urinary Metals. 
Demographic 
Characterisitics  Cd  Pb  Hg  Sb  Ba  Be  Cs  Co  Mo  Pt  Tl  W 
Total  6,043  6,270  1,422  6,110  6,031  6,270  6,270  6,270  6,102  6,270  6,200  6,137 
AGE(years)  
2:[6–12)  776  834  n/a
a   815  796  834  834  834  807  834  824  813 
3:[12–19)  1,461  1,523  297  1,485  1,450  1,523  1,523  1,523  1,477  1,523  1,499  1,483 
4:[19–35)  1,077  1,103  626  1,074  1,071  1,103  1,103  1,103  1,084  1,103  1,091  1,079 
5:[35–50)  918  939  499  912  913  939  939  939  919  939  938  925 
6:[50–65)  800  822  n/a   797  786  822  822  822  802  822  811  803 
7:[65+)  1,011  1,049   n/a  1,027  1,015  1,049  1,049  1,049  1,013  1,049  1,037  1,034 
RACE/ETHNICITY 
Non-Hispanic 
White  2,453  2,532  583  2,485  2,480  2,532  2,532  2,532  2,477  2,532  2,500  2,502 
Non-Hispanic 
Black  1,477  1,511  329  1,498  1,488  1,511  1,511  1,511  1,493  1,511  1,498  1,492 
Mexican 
American  1,712  1,809  400  1,728  1,649  1,809  1,809  1,809  1,729  1,809  1,786  1,730 
GENDER                                     
Male  2,937  3,052  n/a   2,971  2,933  3,052  3,052  3,052  2,966  3,052  3,016  2,978 
Female  3,106  3,218  1,422  3,139  3,098  3,218  3,218  3,218  3,136  3,218  3,184  3,159 
POVERTY INDEX  
Below 
poverty index  1,339  1,403  352  1,369  1,350  1,403  1,403  1,403  1,354  1,403  1,381  1,381 
Above 
poverty index  4,220  4,360  967  4,257  4,215  4,360  4,360  4,360  4,259  4,360  4,320  4,269 
a Data not available for this group. 
 
Table  2  shows  the  creatinine  adjusted  and  unadjusted  geometric  mean  levels  for  the  overall 
population and the four exposure groups (unexposed nonsmokers (nonsmokers); nonsmokers with low 
SHS  exposure  (nonsmokerslow);  nonsmokers  with  high  SHS  exposure  (nonsmokershigh);  and  self-
identified cigarette smokers (smokers)).  
Nonsmokerslow had significantly higher lead (adjusted; p < 0.05 and unadjusted; p < 0.001) and 
antimony (unadjusted; p < 0.01) levels than nonsmokers. There was no significant difference in levels 
of  urine  cadmium,  barium,  cesium,  cobalt,  molybdenum,  platinum,  thallium,  or  tungsten  for 
nonsmokerslow and nonsmokers (Table 2).  
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Table 2. Geometric Means and P-values Overall and by Level of Smoke Exposure for 12 
Urinary Metals. 
Metal 
Creatinine 
Adjustment 
Overall  
Geometric Mean 
metal level 
Nonsmokers  Smokers 
P-value
a  Geometric Mean 
metal level 
without SHS 
Geometric Mean 
metal level with 
Low SHS 
Geometric Mean 
metal level with 
High SHS 
Geometric Mean 
metal level 
Cadmium  Adjusted
b  0.22 (0.21,0.23)  0.21 (0.20,0.22)  0.20 (0.18,0.21)
e  0.16 (0.14,0.17)
f  0.34 (0.30,0.37)
f  0.0000 
Cadmium  Unadjusted
c  0.22 (0.21,0.23)  0.20 (0.19,0.21)  0.21 (0.19,0.23)
d  0.17 (0.15,0.19)
f  0.37 (0.34,0.41)
f  0.0000 
                 
Lead  Adjusted  0.66 (0.64,0.68)  0.61 (0.58,0.63)
d  0.67 (0.64,0.70)  0.68 (0.62,0.73)  0.73 (0.69,0.78)
f  0.0001 
Lead  Unadjusted  0.67 (0.65,0.70)  0.58 (0.55,0.60)
f  0.69 (0.64,0.75)  0.74 (0.66,0.82)  0.82 (0.76,0.89)
f  0.0000 
                 
Mercury  Adjusted  0.65 (0.60,0.71)  0.75 (0.66,0.85)
d  0.60 (0.53,0.67)  0.62 (0.46,0.77)  0.57 (0.51,0.63)
e  0.0053 
Mercury  Unadjusted  0.64 (0.57,0.72)  0.67 (0.57,0.78)  0.59 (0.47,0.71)  0.77 (0.56,0.98)  0.58 (0.48,0.67)   
                 
Antimony  Adjusted  0.11 (0.10,0.12)  0.11 (0.10,0.11)  0.11 (0.10,0.12)  0.11 (0.10,0.12)  0.11 (0.10,0.12)    
Antimony  Unadjusted  0.11 (0.11,0.12)  0.10 (0.10,0.11)
e  0.11 (0.11,0.12)  0.12 (0.11,0.13)  0.13 (0.12,0.14)
f  0.0000 
                 
Barium  Adjusted  1.43 (1.36,1.50)  1.42 (1.34,1.50)  1.43 (1.32,1.55)  1.47 (1.30,1.63)  1.42 (1.31,1.54)    
Barium  Unadjusted  1.47 (1.39,1.55)  1.34 (1.26,1.43)  1.50 (1.36,1.64)  1.60 (1.39,1.81)  1.60 (1.44,1.75)
e  0.0019 
                 
Beryllium  Adjusted  0.09 (0.08,0.09)  0.09 (0.09,0.10)
e  0.08 (0.08,0.09)  0.08 (0.07,0.09)  0.08 (0.07,0.08)
f  0.0000 
Beryllium  Unadjusted  0.09 (0.09,0.09)  0.09 (0.09,0.09)  0.09 (0.09,0.09)  0.09 (0.09,0.09)  0.09 (0.09,0.09)    
                 
Cesium  Adjusted  4.47 (4.35,4.59)  4.86 (4.67,5.05)
e  4.42 (4.25,4.59)
d  4.07 (3.85,4.28)  4.08 (3.93,4.24)
f  0.0000 
Cesium  Unadjusted  4.57 (4.37,4.77)  4.60 (4.34,4.87)  4.60 (4.25,4.95)  4.45 (4.07,4.82)  4.57 (4.28,4.87)    
                 
Cobalt  Adjusted  0.34 (0.33,0.35)  0.35 (0.33,0.37)  0.34 (0.32,0.35)  0.35 (0.33,0.38)
e  0.32 (0.29,0.34)
d  0.0063 
Cobalt  Unadjusted  0.35 (0.33,0.37)  0.33 (0.31,0.35)  0.35 (0.32,0.38)  0.39 (0.35,0.42)  0.35 (0.32,0.38)  0.0246 
               
Molybdenum  Adjusted  41.69(40.19,43.18)  46.33(44.20,48.47)  42.79(40.29,45.29)  41.89(38.86,44.93)
d  32.67(30.77,34.56)
d   0.0000 
Molybdenum  Unadjusted  42.71(40.66,44.76)  43.92(41.35,46.49)  44.63(40.48,48.78)  45.83(40.94,50.72)
d  36.53(33.25,39.81)
d  0.0032 
                 
Platinum  Adjusted  0.03 (0.03,0.04)  0.04 (0.04,0.04)  0.03 (0.03,0.04)  0.03 (0.03,0.03)  0.03 (0.03,0.03)
e  0.0027 
Platinum  Unadjusted  0.04 (0.03,0.04)  0.04 (0.03,0.04)  0.04 (0.03,0.04)  0.04 (0.03,0.04)  0.04 (0.03,0.04)   
                 
Thallium  Adjusted  0.16 (0.16,0.16)  0.17 (0.16,0.17)  0.16 (0.16,0.17)  0.16 (0.15,0.17)
f  0.14 (0.13,0.14)
f  0.0000 
Thallium  Unadjusted  0.16 (0.16,0.17)  0.16 (0.15,0.17)  0.17 (0.16,0.18)  0.17 (0.16,0.19)  0.15 (0.14,0.16)    
                 
Tungsten  Adjusted  0.08 (0.07,0.08)  0.08 (0.07,0.08)  0.08 (0.07,0.08)  0.08 (0.07,0.09)  0.07 (0.06,0.08)   
Tungsten  Unadjusted  0.08 (0.07,0.08)  0.07 (0.07,0.08)  0.08 (0.07,0.09)  0.09 (0.08,0.10)  0.08 (0.07,0.09)  0.0240 
a A statistically significant difference in log transformed mean levels between the exposure groups 
(nonsmoker, nonsmokerlow, nonsmokerhigh, smoker) determined by linear regression.  
b Units are µg/g creatinine.
  
c Units are µg/L. 
For statistical analysis of differences in mean urine metal levels the following t-tests comparisons were 
performed: nonsmokers and nonsmokerslow; nonsmokerslow and nonsmokershigh; nonsmokershigh and 
smokers; smokers and nonsmokers; 
d p-value less than 0.05;  
e p-value less than 0.01;  
f p-value less than 0.001. Int. J. Environ. Res. Public Health 2009, 6                 
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Smokers had higher cadmium,  lead (p < 0.001), antimony (unadjusted; p <  0.001), and barium 
(unadjusted;  p  <  0.01)  levels  than  nonsmokers. Levels  of  some  metals,  including  essential  metals 
cobalt (adjusted; p < 0.05) and molybdenum (p < 0.05), were lower in smokers (Table 2).  
Table 3 presents adjusted and unadjusted geometric mean cadmium levels for exposure groups by 
age, race/ethnicity, gender, and poverty status. Cadmium levels generally increased with age in the 
overall population and  in each exposure group. Except for 65 and older nonsmokershigh that had a 
higher urine cadmium than nonsmokerslow (adjusted; p < 0.01), nonsmokers did not have an increase in 
urine  cadmium  across  the  exposure  groups.  Smokers  19–35  (adjusted;  p  <  0.05  and  unadjusted;  
p < 0.001), 35-50 (p < 0.001), 50-65 (p < 0.001), and 65 and older (p < 0.001) had higher levels than 
did similarly aged nonsmokers. Levels in smokers 35-50, 50-65, and 65 years and older were also 
higher than levels in nonsmokershigh (p < 0.001). Smokers in all racial/ethnic groups had higher levels 
than nonsmokers (p < 0.001).  
 
Table 3. Geometric Means and P-values Overall and by Level of Smoke Exposure and by 
Demographic Characteristics for Cadmium (Cd). 
Demographic 
Characteristics 
Creatinine 
Adjustment 
Overall  
Geometric 
Mean Cd level 
Nonsmokers  Smokers 
P-value
a 
Geometric 
Mean Cd level 
without SHS 
Geometric 
Mean Cd level 
with Low SHS 
Geometric 
Mean Cd level 
with High SHS 
Geometric 
Mean Cd level  
AGE(years) 
2:[6–12)
b  Adjusted
c 
0.09 
(0.08,0.10)  0.08 (0.07,0.10)  0.09 (0.07,0.10)  0.09 (0.08,0.11)  n/a
d     
   Unadjusted
e 
0.08 
(0.07,0.09)  0.08 (0.06,0.09)  0.08 (0.06,0.10)  0.08 (0.07,0.10)  n/a    
3:[12–19)  Adjusted 
0.09 
(0.08,0.09)  0.09 (0.08,0.10)  0.09 (0.08,0.10)  0.08 (0.07,0.09)  0.08 (0.07,0.10)   
   Unadjusted 
0.12 
(0.11,0.13)  0.11 (0.10,0.13)  0.13 (0.11,0.15)  0.12 (0.11,0.14)  0.12 (0.09,0.15)   
4:[19–35)  Adjusted 
0.14 
(0.13,0.15)  0.14 (0.13,0.15)  0.11 (0.09,0.13)  0.13 (0.11,0.15)  0.18(0.16,0.20)
f  0.0005 
   Unadjusted 
0.18 
(0.17,0.20)  0.16 (0.14,0.18)  0.14 (0.10,0.17)  0.19 (0.15,0.22)  0.24(0.20,0.27)
h  0.0002 
5:[35–50)  Adjusted 
0.27 
(0.25,0.29)  0.21 (0.19,0.23)  0.24 (0.20,0.27)  0.22(0.18,0.26)
h  0.45(0.40,0.50)
h  0.0000 
   Unadjusted 
0.28 
(0.25,0.30)  0.21 (0.18,0.24)  0.26 (0.22,0.29)  0.22(0.17,0.27)
h  0.45(0.39,0.50)
h  0.0000 
6:[50–65)  Adjusted 
0.40 
(0.37,0.43)  0.33 (0.30,0.37)  0.38 (0.31,0.45)  0.36(0.30,0.42)
h  0.67(0.58,0.76)
h  0.0000 
   Unadjusted 
0.35 
(0.32,0.39)  0.28 (0.25,0.32)  0.34 (0.27,0.41)  0.30(0.19,0.41)
h  0.65(0.54,0.76)
h  0.0000 
7:[65+)  Adjusted 
0.46 
(0.43,0.49)  0.43 (0.39,0.46)  0.40(0.36,0.43)
g  0.54(0.46,0.63)
h  1.04(0.90,1.18)
h  0.0000 
   Unadjusted 
0.36 
(0.33,0.39)  0.31 (0.28,0.35)  0.35 (0.29,0.40)  0.43(0.34,0.51)
h  0.90(0.72,1.08)
h  0.0000 
RACE/ETHNICITY 
Non-
Hispanic 
White  Adjusted 
0.23 
(0.21,0.24)  0.22 (0.20,0.23)  0.21(0.18,0.24)
g  0.15(0.14,0.17)
h  0.34(0.30,0.38)
h  0.0000 
   Unadjusted 
0.22 
(0.20,0.23)  0.20 (0.18,0.21)  0.20(0.18,0.23)
f  0.16(0.14,0.18)
h  0.34(0.30,0.38)
h  0.0000 Int. J. Environ. Res. Public Health 2009, 6                 
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Table 3. Cont. 
Non-
Hispanic 
Black  Adjusted 
0.20 
(0.18,0.21)
j  0.19 (0.17,0.22)  0.16 (0.14,0.18)
i 
0.15 
(0.13,0.17)
h 
0.36 
(0.30,0.42)
h  0.0000 
   Unadjusted 
0.29 
(0.26,0.32)
k  0.27 (0.23,0.32)
j  0.23 (0.20,0.26) 
0.21 
(0.18,0.24)
h,j 
0.60 
(0.50,0.70)
h,k  0.0000 
Mexican 
American  Adjusted 
0.18 
(0.16,0.19)
k  
0.17 
(0.16,0.19)
k  0.16 (0.14,0.18)
j 
0.15 
(0.12,0.17)
h 
0.28 
(0.23,0.34)
h  0.0000 
   Unadjusted 
0.19 
(0.18,0.21)
i  0.17 (0.16,0.19)
i  0.18 (0.16,0.21) 
0.16 
(0.13,0.19)
h 
0.36 
(0.30,0.41)
h  0.0000 
GENDER 
Male  Adjusted 
0.18 
(0.17,0.19)  0.16 (0.15,0.17)  0.16 (0.14,0.18) 
0.13 
(0.12,0.15)
h 
0.29 
(0.25,0.32)
h  0.0000 
   Unadjusted 
0.22 
(0.21,0.23)  0.19 (0.18,0.21)  0.20 (0.17,0.23) 
0.16 
(0.13,0.18)
h 
0.38 
(0.33,0.43)
h  0.0000 
Female  Adjusted 
0.26 
(0.25,0.28)
k 
0.26 
(0.24,0.27)
k 
0.25 
(0.22,0.28)
h,k 
0.18 
(0.16,0.20)
h,k 
0.40 
(0.35,0.45)
h,k  0.0000 
   Unadjusted 
0.23 
(0.21,0.24)  0.20 (0.19,0.22)  0.21 (0.19,0.24) 
0.19 
(0.16,0.21)
h 
0.37 
(0.32,0.42)
h  0.0000 
POVERTY INDEX 
Below 
poverty index  Adjusted 
0.20 
(0.18,0.21)  0.19 (0.17,0.22)  0.17 (0.14,0.20) 
0.14 
(0.12,0.16)
h 
0.31 
(0.27,0.36)
h  0.0000 
   Unadjusted 
0.23 
(0.20,0.25)  0.19 (0.16,0.22)  0.21 (0.17,0.25) 
0.16 
(0.14,0.18)
h 
0.40 
(0.33,0.47)
h  0.0000 
Above 
poverty index  Adjusted 
0.22 
(0.21,0.23)  0.21 (0.20,0.22) 
0.20 
(0.18,0.22)
g 
0.16 
(0.14,0.17)
h 
0.34 
(0.30,0.38)
h  0.0000 
   Unadjusted 
0.22 
(0.21,0.23)  0.20 (0.18,0.21)  0.20 (0.18,0.23) 
0.17 
(0.15,0.19)
h 
0.37 
(0.32,0.42)
h  0.0000 
a A statistically significant difference in log transformed mean levels between the exposure groups 
(nonsmoker, nonsmokerlow, nonsmokerhigh, smoker) determined by linear regression. 
b For age categories, a square bracket indicates inclusion of the interval end point, and a parenthesis 
indicates exclusion. 
c Units are µg/g creatinine.
  
d Not applicable.
 
e Units are µg/L. 
For statistical analysis of differences in mean urine metal levels the following t-tests comparisons were 
performed: nonsmokers and nonsmokerslow; nonsmokerslow and nonsmokershigh; nonsmokershigh and 
smokers; smokers and nonsmokers; and nonsmoker vs. nonsmokerhigh for children aged 6–11 years;  
f p-value less than 0.05; 
g p-value less than 0.01; 
h p-value less than 0.001. For statistical analysis of 
differences in mean urine cadmium levels across group comparisons, the following t-test comparisons 
were performed: non-Hispanic black versus non-Hispanic white, Mexican American versus non-Hispanic 
white, and female versus male; 
i p-value less than 0.05; 
j p-value less than 0.01; 
k p-value less than 0.001. 
 
Analysis of unadjusted data show that, except for nonsmokerslow, non-Hispanic blacks had higher 
cadmium levels than non-Hispanic whites (nonsmokers, p < 0.01; nonsmokerhigh, p < 0.01; smokers,  
p < 0.001). When means were creatinine adjusted, non-Hispanic blacks had lower or similar levels 
than non-Hispanic whites. Mexican Americans overall (adjusted; p < 0.001 and unadjusted; p < 0.05), 
Mexican  American  nonsmokers  (adjusted;  p  <  0.001  and  unadjusted;  p  <  0.05),  and  Mexican 
American  nonsmokerslow  (adjusted;  p  <  0.01)  had  lower  urine  cadmium  levels  than  
non-Hispanic whites.  Int. J. Environ. Res. Public Health 2009, 6                 
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Male and female smokers had higher adjusted and unadjusted cadmium levels than nonsmokers  
(p  <  0.001).  Male  and  female  nonsmokers  did  not  have  an  increase  in  urine  cadmium  across the 
exposure groups. Females (all exposure groups) had higher adjusted levels than males (p < 0.001). 
Levels of cadmium in the urine of smokers above and below the poverty threshold were higher than 
levels of nonsmokers (p < 0.001). Nonsmokers above and below the poverty threshold did not have an 
increase in urine cadmium across the exposure groups. 
Table 4 presents adjusted and unadjusted geometric mean lead levels for all exposure groups by 
age,  race/ethnicity,  gender,  and  poverty  status.  Among  6-12  year  olds,  nonsmokershigh  had  higher 
levels than nonsmokers (adjusted; p < 0.001 and unadjusted; p < 0.05) or nonsmokerslow (adjusted;  
p < 0.01). Excluding youth 6-12 years, levels generally increased with age in the overall population 
and  for  all  exposure  groups.  Although  12-19  year  old  nonsmokerslow  (adjusted;  p  <  0.05  and 
unadjusted;  p  <  0.01)  had  higher  urine  lead  levels  than  12-19  year  old  nonsmokers,  most  age 
categories  did  not  have  an  increase  in  urine  lead  across  the  exposure  groups.  Smokers  12-19 
(unadjusted; p < 0.05), 19-35 (p < 0.001), 35-50 (p < 0.001), 50-65 (p < 0.001), and 65 years and older 
(adjusted; p < 0.05 and unadjusted; p < 0.001) had significantly higher levels than did nonsmokers.  
 
Table 4. Geometric Means and P-values Overall and by Level of Smoke Exposure and 
Demographic Characteristics for Lead (Pb). 
Heavy Metal 
Creatinine 
Adjustment 
Overall  
Geometric 
Mean Pb level 
Nonsmokers  Smokers 
P-value
a 
Geometric 
Mean Pb level 
without SHS  
Geometric 
Mean Pb level 
with Low SHS 
Geometric 
Mean Pb level 
with High SHS 
Geometric 
Mean Pb level 
AGE (years) 
2:[6–12)
b  Adjusted
c  0.97 (0.90,1.03)  0.85 (0.77,0.93)  0.89(0.80,0.99)
g  1.17(1.03,1.30)
h  n/a
d  0.0005 
   Unadjusted
e  0.87 (0.79,0.94)  0.78 (0.69,0.87)  0.79 (0.67,0.91)  1.04(0.87,1.20)
f   n/a  0.0153 
3:[12–19)  Adjusted  0.43 (0.41,0.44)  0.39(0.36,0.42)
f  0.48 (0.43,0.53)  0.44 (0.39,0.49)  0.42 (0.38,0.46)  0.0390 
   Unadjusted  0.59 (0.55,0.62)  0.49(0.45,0.54)
g  0.67 (0.58,0.77)  0.66 (0.58,0.75)  0.63(0.53,0.73)
f  0.0008 
4:[19–35)  Adjusted  0.48 (0.45,0.51)  0.42 (0.38,0.46)  0.48 (0.43,0.52)  0.47 (0.40,0.53)  0.56(0.50,0.61)
h  0.0005 
   Unadjusted  0.61 (0.56,0.65)  0.48 (0.42,0.54)  0.59 (0.52,0.67)  0.66 (0.52,0.79)  0.76(0.65,0.87)
h  0.0001 
5:[ 35–50)  Adjusted  0.65 (0.61,0.69)  0.56 (0.51,0.61)  0.59 (0.53,0.65)  0.64(0.54,0.74)
g  0.84(0.75,0.94)
h  0.0000 
   Unadjusted  0.66 (0.61,0.71)  0.55 (0.50,0.60)  0.64 (0.52,0.77)  0.65 (0.52,0.79)  0.84(0.75,0.93)
h  0.0000 
6:[50–65)  Adjusted  0.80 (0.75,0.85)  0.72 (0.67,0.78)  0.83 (0.75,0.91)  0.81 (0.67,0.95)  0.96(0.85,1.08)
h  0.0002 
   Unadjusted  0.71 (0.64,0.78)  0.62 (0.55,0.68)  0.74 (0.64,0.85)  0.67 (0.42,0.92)  0.94(0.78,1.10)
h  0.0001 
7:[65+)  Adjusted  0.91 (0.87,0.95)  0.88 (0.83,0.93)  0.92 (0.84,1.00)  0.99 (0.80,1.18)  1.11(0.96,1.26)
f  0.0318 
   Unadjusted  0.72 (0.66,0.77)  0.64(0.59,0.70)
f  0.81 (0.70,0.92)  0.79 (0.62,0.97)  0.98(0.82,1.15)
h  0.0008 
RACE/ETHNICITY  
Non-
Hispanic 
White  Adjusted  0.64 (0.62,0.66)  0.59(0.56,0.63)
f  0.66 (0.62,0.69)  0.63 (0.57,0.70)  0.71(0.66,0.76)
g  0.0011 
   Unadjusted  0.61 (0.58,0.64)  0.54(0.51,0.57)
f  0.64 (0.58,0.70)  0.65 (0.55,0.74)  0.72(0.65,0.78)
h  0.0001 
Non-
Hispanic 
Black  Adjusted  0.66 (0.61,0.71)  0.55 (0.50,0.59)  0.59(0.54,0.64)
h  0.73 (0.64,0.82)  0.82(0.71,0.92)
h  0.0000 
   Unadjusted 
0.96 (0.89,1.03)
 
k 
0.76 
(0.69,0.83)
k 
0.83(0.72,0.94)
f,
j 
1.04(0.92,1.16)
f,
k 
1.34(1.19,1.50)
h,
k  0.0000 
Mexican 
American  Adjusted 
0.81 
(0.77,0.86)
k 
0.79 
(0.75,0.83)
k 
0.83 
(0.76,0.91)
k  0.79 (0.64,0.93)  0.89 (0.75,1.03)
i   
   Unadjusted 
0.87 
(0.81,0.92)
k 
0.79 
(0.72,0.85)
k 
0.94 
(0.82,1.06)
k  0.87 (0.76,0.97)
j 
1.13(0.95,1.30)
h,
k  0.0002 Int. J. Environ. Res. Public Health 2009, 6                 
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Table 4. Cont. 
GENDER 
Male  Adjusted  0.65 (0.62,0.67)  0.56(0.53,0.59)
h  0.70 (0.65,0.76)  0.67 (0.59,0.74)  0.73(0.68,0.77)
h  0.0000 
   Unadjusted  0.80 (0.76,0.84)  0.69(0.64,0.73)
h  0.87 (0.78,0.96)  0.78 (0.65,0.92)  0.95(0.86,1.04)
h  0.0000 
Female  Adjusted  0.67 (0.64,0.69) 
0.65 
(0.61,0.68)
k  0.63 (0.60,0.67)
i  0.69 (0.62,0.75)  0.74 (0.67,0.82)  0.0494 
   Unadjusted 
0.58 
(0.55,0.60)
k 
0.51 
(0.48,0.54)
k 
0.56(0.50,0.61)
f,
k  0.70 (0.61,0.79) 
0.70(0.62,0.77)
h,
k  0.0000 
POVERTY INDEX 
Below 
poverty index  Adjusted  0.74 (0.68,0.79)  0.70 (0.62,0.78)  0.70 (0.61,0.78)  0.81 (0.69,0.94)  0.73 (0.64,0.83)   
   Unadjusted  0.84 (0.78,0.91)  0.68 (0.59,0.77)  0.83 (0.72,0.95)  0.95 (0.81,1.09)  0.93(0.80,1.07)
f  0.0015 
Above 
poverty index  Adjusted  0.63 (0.61,0.65)  0.59(0.56,0.62)
f  0.65 (0.61,0.68)  0.64 (0.58,0.69)  0.72(0.66,0.77)
h  0.0007 
   Unadjusted  0.63 (0.61,0.66)  0.56(0.53,0.59)
g  0.65 (0.60,0.71)  0.68(0.60,0.77)
f  0.78(0.70,0.86)
h  0.0000 
a A statistically significant difference in log transformed mean levels between the exposure groups 
(nonsmoker, nonsmokerlow, nonsmokerhigh, smoker) determined by linear regression.  
b For age categories, a square bracket indicates inclusion of the interval end point, and a parenthesis 
indicates exclusion. 
c Units are µg/g creatinine.
  
d Not applicable.
 
e Units are µg/L. 
For statistical analysis of differences in mean urine metal levels the following t-tests comparisons were 
performed: nonsmokers and nonsmokerslow; nonsmokerslow and nonsmokershigh; nonsmokershigh and 
smokers; smokers and nonsmokers; and nonsmoker vs. nonsmokerhigh for children aged 6–11 years.  
f p-value less than 0.05; 
g p-value less than 0.01; 
h p-value less than 0.001. For statistical analysis of 
differences in mean urine lead levels across group comparisons, the following t-test comparisons were 
performed: non-Hispanic black versus non-Hispanic white, Mexican American versus non-Hispanic 
white, and female versus male. 
i p-value less than 0.05; 
j p-value less than 0.01; 
k p-value less than 0.001.  
 
Both adjusted and unadjusted lead levels were higher in non-Hispanic white (adjusted; p < 0.01 and 
unadjusted p < 0.001) and non-Hispanic black smokers (p < 0.001) than in nonsmokers. Non-Hispanic 
black  nonsmokershigh  had  higher  levels  than  nonsmokerslow (adjusted;  p  <  0.001  and  unadjusted;  
p  <  0.05).  Only  the  unadjusted  level  was  higher  in  Mexican  American  smokers  than  nonsmokers  
(p < 0.001). Mexican American nonsmokers did not have an increase in urine lead across the exposure 
groups. 
Across all levels of smoke exposure, non-Hispanic blacks (nonsmokers p < 0.001; nonsmokerslow  
p  <  0.01;  nonsmokershigh  p  <  0.001;  smokers  p  <  0.001)  and  Mexican  Americans  (nonsmokers  
p  <  0.001;  nonsmokerslow  p  <  0.001;  nonsmokershigh  p  <  0.01;  smokers  p  <  0.001)  had  higher 
unadjusted  lead  levels  than  non-Hispanic  whites.  After  adjusting  for  creatinine  content,  some 
differences remained among Mexican American nonsmokers (p < 0.001), nonsmokerslow (p < 0.001), 
and smokers (p < 0.05).  
Adjusted  and  unadjusted  lead  levels  in  male  smokers  were  higher  than  in  male  nonsmokers  
(p < 0.001). In female smokers, only the unadjusted level was higher than nonsmokers (p < 0.001). In 
general,  unadjusted  levels  were  significantly  lower  in  females  than  males.  Female  nonsmokers, 
however, had significantly higher adjusted levels than male nonsmokers (p < 0.001). Int. J. Environ. Res. Public Health 2009, 6                 
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When considering poverty status, adjusted and unadjusted lead levels of smokers above the poverty 
threshold  were  higher  than  levels  in  nonsmokers  (p  <  0.001).  Nonsmokerslow  above  the  poverty 
threshold had higher urine lead levels than nonsmokers above the poverty threshold (adjusted; p < 0.05 
and unadjusted p < 0.01). For smokers below the poverty threshold, only the unadjusted urine lead 
level was higher than the level in nonsmokers (p < 0.05). Nonsmokers below the poverty threshold did 
not have an increase in urine lead across the exposure groups.  
Our  findings  show that  some  metals  are  increased  (e.g.,  cadmium  and  lead,  and  antimony  and 
barium [unadjusted]) in smokers, while others are lower (e.g., mercury, beryllium, cesium, cobalt, 
molybdenum,  platinum,  and  thallium  [adjusted])  or  unchanged  (tungsten).  In  general,  metals  are 
absorbed in the lung, tend to persist in the body with half-lives of years to decades, and most are 
excreted through the kidneys and gastrointestinal tract [22]. So it is plausible that nontrivial exposures 
will be detectable in urine. Consequently, our findings of lower or unchanged urine levels suggest that, 
for  the  general  population,  cigarette  smoke  is  not  a  major  environmental  source  of  exposure  to 
mercury, beryllium, cesium, cobalt, molybdenum, platinum, thallium, or tungsten. 
Lead  and  cadmium  are  emphasized  because  of  their  well  established  toxicity  and  tendency  to 
accumulate in the body [13,14]. It is therefore particularly noteworthy that the highest lead levels were 
among nonsmokershigh 6–12 years, the youngest in our study population. It may be that the youth-adult 
disparity in SHS exposure, which has increased since the early 1990s [9], is contributing to children’s 
lead levels. This hypothesis is supported by others’ observations of high blood lead levels in children 
of smoking parents [3]. It has been suggested that smoking’s contribution to lead levels has become 
increasingly relevant as gasoline lead emissions have declined [3].
 We found that, with few exceptions, 
adult nonsmokershigh and smokers had similarly high lead levels. Thus, while other potential sources of 
lead exposure were not assessed, our findings suggest that SHS exposure may be sufficient to produce 
a  measurable,  dose-dependent  increase  in  lead  levels.  We  also  observed  that  only  SHS-exposed 
nonsmokers above the poverty threshold had elevated urine lead. This suggests that tobacco smoke is 
an important source of lead exposure for those with higher household income and raises questions 
about other environmental exposures, across income and socioeconomic levels. Future studies of SHS-
exposed  children  should  be  designed  to  address  the  possible  contribution  of  early  childhood 
environmental exposures to lead. 
We  also  observed  high  barium  and  antimony  in  smokers  compared  to  nonsmokers.  As  with 
cadmium  and  lead,  barium  and  antimony  are  present  in  cigarette  smoke  [11,12].  Animal  studies 
indicate that inhaled barium is primarily excreted in the feces [23].
 In contrast, cadmium and absorbed 
lead are eliminated primarily in the urine [13,24]. Although only unadjusted barium was significantly 
elevated, the finding raises mechanistic considerations. For example, the amount of barium received by 
a smoker may exceed the normal renal capacity for tubular reabsorption through common competitive 
transcellular  pathways  [25]  when  exposure  occurs  in  the  presence  of  other  divalent  metals  (e.g., 
cadmium).  Kidney  effects  are  the  most  sensitive  endpoint  following  chronic  barium  exposure  in 
laboratory animals [26] and one possible area of research is to investigate barium as a direct renal 
toxicant  in  smokers.
  Cadmium  and  lead  are  renal  toxicants  in  humans  and  cadmium  urine 
concentrations increase after kidney damage [25,27]. Renal tubular toxicity and low bone density are 
reported at urine cadmium levels as low as 1 µg/g [21,28]. Cadmium levels among older smokers in 
our  study  approach  this  level.  Consequently,  elevated  urine  barium  among  smokers  may  reflect Int. J. Environ. Res. Public Health 2009, 6                 
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decreased  tubular  reabsorption  in  a  kidney  damaged  by  exposure  to  cadmium  or  other  metals. 
Antimony  is  excreted  in  the  urine  and  feces  [29].  Occupational  and  animal  studies  have  reported 
respiratory and cardiovascular effects from inhalation of antimony compounds [29]. A recent study 
reported a sharp increase in risk of peripheral artery disease in individuals with low urine antimony 
levels below 0.1 µg/L and a persistent elevated risk above 0.1 µg/L compared with those with urine 
antimony at the limit of detection [7]. In our study, unadjusted urine antimony levels increased across 
exposure groups with smokers having the highest level of 0.13 µg/L. Oxidative stress is proposed to 
play a role in the toxicity and carcinogenicity of some metals (including cadmium, lead, and antimony) 
in tobacco smoke [30].
  
There  are  inverse  relations  between  smoking  and  levels  of  important  nutrients,  independent  of 
dietary  intake  [31].  We  observed  that  smokers  had  significantly  lower  cobalt  and  molybdenum 
(adjusted) than nonsmokers. Our findings are similar to those reported for current vs. former or never 
smokers  [32].  While  human  cobalt  deficiencies  have  not  been  reported,  cobalt  is  a  component  of 
vitamin B12 and smoking interferes with absorption of vitamin B12 [32,33]. Molybdenum is a co-factor 
for oxidoreductases such as xanthine oxidase [33]. Molybdenum-deficient soil has been considered a 
possible factor in regions with high rates of esophageal cancer [34,35]. An area of possible research is 
the relation between smoking, reduced levels of essential elements, and smoking-related morbidities 
and co-morbidities. Additional research is needed to determine if smokers have reduced cobalt and 
molybdenum due to dietary deficiencies or independent of other potentially confounding variables. 
Our  study  is  subject  to  several  possible  limitations.  First,  because  our  nonsmoker  definition 
consisted of those that reported not smoking in the last five days, the upper ranges of SHS-exposed 
nonsmokers may include recent quitters and it is also possible that SHS-exposed nonsmokers included 
misidentified  occasional  smokers  whose  cotinine  levels  can  overlap  with  SHS-exposed  
nonsmokers  [36].  Dual  characterization  of  nonsmoker  status  by  self-report  and  serum  cotinine 
eliminated nonsmokers with cotinine > 10 ng/mL. If the cotinine measurement condition is omitted 
from our nonsmoker definition, the estimated number of nonsmokers would increase by only 1%. 
Other potential confounders not considered in our analyses are dietary sources of metals, hobbies 
involving metals, lead paint in the home, urban residence, or occupation. Information on some of these 
potential confounders (e.g., hobbies involving metals) is not available for the NHANES population. 
Compared with workers in some industries, however, the prevalence of elevated exposures to metals 
such as lead, cadmium, or antimony in the general population is low and occupational exposure in the 
NHANES population is expected to be rare [7]. Consequently, an assumption in our study is that while 
these potential confounders may differentially impact population groups—in particular those of lower 
socioeconomic status—for lead, the impact is  likely  minimal given the few variations  observed in 
comparisons  of  those  above  and  below  the  poverty  threshold.  Confounding  from  other  potential 
sources of metal exposure should be carefully addressed in studies concerned
 with causality.  
The representative nature of the data was an important strength as this enables some generalizability 
of the results. For example, we observed higher adjusted cadmium for females for all exposure groups 
and, like others [21], also higher levels in females in the overall sample.  Additionally, including 6 
years of data, including the over-sampling of Mexican Americans and non-Hispanic blacks, allowed 
adequate power for race/ethnicity comparisons. We found racial/ethnic differences in cadmium and 
lead. For example, non-Hispanic white nonsmokerslow had higher adjusted cadmium than did  non-Int. J. Environ. Res. Public Health 2009, 6                 
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Hispanic blacks or Mexican Americans. Also, nonsmoking Mexican Americans with no or low SHS 
exposure had higher lead than non-Hispanic whites. Non-Hispanic blacks had the highest unadjusted 
lead in the overall sample, amongst nonsmokershigh, and smokers. After adjustment, the differences 
were no longer significant. This observation may be explained by the significantly greater creatinine 
concentrations  among  non-Hispanic  blacks  than  non-Hispanic  whites  or  Mexican  Americans  [37].
 
Adjusting for creatinine content resulted in differences across exposure groups becoming significant 
for 6 metals: mercury, beryllium, cesium, cobalt, platinum, and thallium. Presenting both adjusted and 
unadjusted concentrations illustrates the importance of considering the appropriateness of creatinine 
correction based on the study population and the research questions. 
Blood lead measurements are preferred to evaluate lead exposure [21]. Thus, a second limitation of 
the study is that urine lead measurements are more variable than blood levels [21]. It is possible that 
blood  lead  with  less  intra-individual  variability  may  show  different  patterns  in  smoke-exposed 
individuals. In contrast, urine cadmium is a more reliable measure of chronic cadmium exposure than 
blood cadmium [7]. 
Although  our  study  addresses  12  metals  previously  reported  in  tobacco  smoke,  it  is  not  an 
exhaustive  analysis  of  all  metals  in  tobacco  smoke.  Data  for  several  toxicologically-important 
chemicals (e.g., chromium, nickel, and arsenic) are not available for all waves of NHANES data in this 
study. Additionally, NHANES urine metals data are not available for children younger than 6 years. 
Finally, the study does not consider co-morbidities such as decreased renal function.  
For  some  metals  (e.g.,  mercury  and  thallium),  our  data  suggest  that  tobacco  smoke  is  not  a 
significant  source  of  exposure  because  levels  were  higher  among  nonsmokers  than  smokers. 
Counterfeit cigarettes can contain higher levels of toxic metals (e.g., cadmium, lead, and thallium) than 
legal cigarettes [38]. Consequently, consumption of counterfeit cigarettes or cigarettes with tobacco 
grown in sludge amended soil may exacerbate the problem [39].  
 
3. Experimental Section 
 
All data were obtained from the NHANES series conducted by the Centers for Disease Control and 
Prevention’s  (CDC’s)  National  Center  for  Health  Statistics  (http://www.cdc.gov/nchs/nhanes.htm). 
NHANES is representative of civilian, noninstitutionalized residents of the United States 2 months or 
older. Three waves of NHANES data were included: 1999–2000, 2001–2002, and 2003–2004. The 
analysis  file  was  limited  to  respondents  who  completed the  health  examination  component  of  the 
survey, those with serum cotinine, urine creatinine, and the urine metals antimony, barium, beryllium, 
cadmium,  cesium,  cobalt,  lead,  mercury,  molybdenum,  platinum,  thallium,  and  tungsten 
measurements,  and  those  that  responded  to  tobacco  questions.  Urine  metals  were  measured  for 
participants 6 years or older. The tobacco questions were asked of respondents 12 years or older.  
The final analysis file contained 6,312 respondents with the laboratory measurements, smoker or 
nonsmoker  status  based  on  responses  to  the  tobacco  questions  and  serum  cotinine  levels  (further 
described  below),  and  a  valid  (nonzero)  weight  variable.  The  development  of  the  analysis  file  is 
presented in Figure 1. 
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Figure 1. Analytic sample. 
 
 
Respondents 12 years or older who answered ―No‖ to the question, ―During the past 5 days, did you 
use  any  product  containing  nicotine  including  cigarettes,  pipes,  cigars,  chewing  tobacco,  snuff, 
nicotine patches, nicotine gum, or any other product containing nicotine‖ were considered nontobacco 
users. Any participant younger than 12 years was considered a nontobacco user, but was excluded if 
their cotinine was ≥ 10 ng/ml because nonsmokers in NHANES have been defined by others [40] as 
persons with serum cotinine < 10 ng/mL. Self-reported nontobacco users 12 years or older with a 
cotinine measurement ≥ 10 ng/mL were also excluded from the analyses. A nonsmoker was defined as 
a  self-reported  nontobacco  user  with  a  cotinine  measurement  <  10  ng/mL.  Nineteen  self-reported 
nonsmokers in the final analytic sample had cotinine levels above 10 ng/mL and were excluded.   
Smokers  were  defined  as  respondents  12  years  or  older  whose  only  direct  source  of  nicotine 
exposure was cigarettes. Smokers were those who answered ―Yes‖ to the question, ―During the past 5 
days, did you use any product containing nicotine including cigarettes, pipes, cigars, chewing tobacco, 
snuff, nicotine patches, nicotine gum, or any other product containing nicotine‖ and did not use non-
cigarette sources of nicotine as indicated by answering ―No‖ to additional questions asking if they 
smoked  pipes,  cigars,  used  chewing  tobacco,  snuff  or  other  nicotine  products  in  the  past  5  days. 
Smokers that used other non-cigarette sources of nicotine were excluded. 
For cotinine levels below the level of detection, we used an estimated value of 0.035 ng/mL (i.e., 
level of detection, 0.050 ng/mL, divided by the square root of 2) when calculating geometric mean 
urine levels following procedures outlined in previous research [41]. Due to the highly skewed nature 
of cotinine levels in the study population [40], the geometric mean of cotinine, 0.256 ng/mL, was 
chosen as the cutoff point to define low and high SHS exposures. Exposure was categorized into four 
levels:  self-identified,  unexposed  nonsmokers  (nonsmokers)  —  nonsmokers  with  
cotinine ≤ 0.035 ng/mL; nonsmokers with low SHS exposure (nonsmokerslow) — nonsmokers with 
cotinine > 0.035 ng/mL and ≤ 0.256 ng/mL; nonsmokers with high SHS exposure (nonsmokershigh) —
Participants with lab 
measures AND 
tobacco questions or 
ages 6-12: 6,960 
 
      
 
Participants without 
lab measures OR 
tobacco questions: 
17,488 
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AND with health 
exam: 24,448 
 
Participants without 
cotinine measure for 
smokers: 483 
Participants with 
cotinine measure 
OR nonsmokers: 
6,477 
 
      
 
Participants whose 
self-reports are 
inconsistent with 
cotinine cut point (10 
ng/mL): 165     
Participants categorized 
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Participants categorized 
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NHANES participants 
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     31,126 
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nonsmokers with cotinine > 0.256  ng/mL and ≤ 10 ng/mL; and smokers—self-identified cigarette 
smokers with cotinine > 10 ng/mL. 146 self-reported smokers in the final analytic sample had cotinine 
levels below 10 ng/mL. 
Participants  who  described  themselves  as  ―non-Hispanic  white,‖  ―non-Hispanic  black,‖  and 
―Mexican  American‖  were  assessed  and  findings  for  these  racial/ethnic  subgroups  are  presented. 
―Other race/ethnicity,‖ were included in total population estimates but were not presented due to the 
small number of participants in this category. Participant age was categorized into 6 groups: 6–11,  
12–18, 19–34, 35–49, 50–64, and 65 years and older.  
The poverty-to-income ratio (PIR)—the ratio between family income and the poverty threshold, 
based on income thresholds that vary by family size and composition that are updated annually for 
inflation with the Consumer Price Index (U.S. Census Bureau, 2003, 2007) — was used to create a 
dichotomous variable to indicate if the participant was above (> 1.00) or below the poverty threshold  
(< 1.00). The poverty threshold was used as an indicator of socioeconomic status (SES). As reported in 
previous NHANES research [42], poverty is a useful indicator of SES because, unlike other indicators 
of SES like education or occupation, it provides a comparable measure of SES across a broad range of 
ages. 
Biological samples (blood and urine) were collected during a standardized physical examination 
conducted in a mobile examination center (MEC) and stored cold or frozen until laboratory analyses 
were  conducted.  Serum  cotinine  was  measured  by  a  high-performance  liquid 
chromatography/atmospheric-pressure ionization tandem mass spectrometry (LC/MS/MS) method that 
has been described previously [43]. Urine metals were measured by inductively coupled plasma-mass 
spectrometry  as  described  previously  [44].  Urine  creatinine  was  measured  using  an  automated 
colorimetric determination based on a modified Jaffe reaction  [37]. Further descriptions of sample 
collection  and  laboratory  methods  for  cotinine,  creatinine,  and  the  metals  are  available  at: 
http://www.cdc.gov/nchs/nhanes.htm. Two sets of urine metal measures were created. One is the metal 
concentration adjusted for the creatinine content of the urine (µg/g creatinine) (adjusted). Creatinine 
correction adjusts for urine dilution and is typically performed with spot urine samples [37]. The other 
is the unadjusted urine metal concentration (µg/L) (unadjusted). Creatinine correction is commonly 
used  in  homogeneous  populations;  however,  multiple  demographic  groups,  such  as  in  this  study, 
increase  the  variability  in  creatinine  levels  [37,45].  Cadmium  levels  in  the  1999-2002  data  were 
corrected for molybdenum oxide interference. The correction resulted in corrected values less than 
zero  being  assigned  a  value  of  zero  (http://www.cdc.gov/nchs/data/nhanes/frequency/ 
lab06hm_doc.pdf). There were 49 cases with zero values in the final analytic sample. All zero values 
were set to missing in the analysis file to insure proper generation of the geometric mean.  
We calculated estimates using the sub-sampling weights to represent nonsmokers ≥ 6 years and 
smokers ≥ 12 years in the United States. In 1999–2002, urine mercury was only measured for females 
16–49 years. Starting in 2003, urine mercury was measured for males and females ≥ 6 years. For 
consistency  across  all  3  waves  of  data,  the  mercury  analysis  only  included  data  for  females  
16–49 years.  
Sampling weights provide population estimates that adjust for unequal probabilities of selection and 
account for nonresponses. The weights were post-stratified to the U.S. population as estimated by the 
Census Bureau. For use with multi-wave data, we calculated analytic survey weight following the Int. J. Environ. Res. Public Health 2009, 6                 
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NHANES  documentation  provided  on  their  website.  Specifically,  this  involved  taking  2/3  of  the 
special four-year MEC weight for 1999-2002 and 1/3 of the two-year MEC weight for 2003-2004. For 
analyses, we used SAS (SAS Institute, Inc., Cary, NC) and SUDAAN (Research Triangle Institute, 
Research  Triangle  Park,  NC)—a  program  that  adjusts  for  complex  sample  design  when  variance 
estimates are calculated. 
Estimates for the geometric mean, with 95% confidence intervals, were calculated by demographic 
characteristic and for each exposure level. A linear regression analysis was then used to identify metals 
whose geometric mean is significantly different between the exposure groups, with log transformations 
of adjusted or unadjusted metal concentrations as the dependent variable and exposure group as the 
independent  variable.  If  an  overall  difference  was  significant  between  the  groups,  t-tests  were 
performed  to  identify  the  specific  difference(s)  for  exposure  group  pairs.  T-test  comparisons  for 
participants 12 years or older were ―nonsmoker vs. nonsmokerlow‖, ―nonsmokerlow vs. nonsmokerhigh‖, 
―nonsmokerhigh vs. smoker‖ and ―nonsmoker vs. smoker‖. For children 6–11 years, t-test comparisons 
were  ―nonsmoker  vs.  nonsmokerlow‖,  ―nonsmokerlow  vs.  nonsmokerhigh‖  and  ―nonsmoker  vs. 
nonsmokerhigh‖. Additional analyses were performed to examine differences in cadmium or lead levels 
across race/ethnicity and between genders. The comparison reference group for race/ethnicity is non-
Hispanic white and for gender is male. Bonferroni correction was used to control the type I errors on 
multiple comparisons.  
 
4. Conclusions 
 
The  U.S.  Surgeon  General’s  recent  declaration  of  no  risk-free  level  of  SHS  exposure  [1] 
underscores the importance of characterizing active and passive exposures to harmful tobacco smoke 
constituents. Some chemicals, notably cadmium and lead, will accumulate in the body. Our findings 
show SHS-exposed children, a population particularly vulnerable to the toxic effects of lead at low 
levels of exposure [15,16] have higher levels of urine lead than children without SHS exposure. Urine 
lead levels respond rapidly to changes in body lead and increase with increasing lead exposure [46] 
and our findings suggest the need for confirmatory study of blood lead levels among SHS exposed 
youth. Older smokers in our study had cadmium levels high enough to raise concerns that they are at 
risk for cadmium-related toxicity. Thus, our findings indicate that active and passive smoking should 
be  considered  in  future  investigations  to  ascertain  the  role  of  metals  in  the  disease  process.  This 
finding is especially relevant for some minorities and socio-economically disadvantaged groups [47]. 
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